Jump to content

Recommended Posts

Posted

Has anyone heard of giving nebulized lasix? This article is pretty interesting.

Credit is posted at the bottom of the article which I display here.

THE USE OF NEBULIZED MEDICATIONS

FOR THE TREATMENT OF DYSPNEA

Defining Dyspnea and its Impact on Quality of Life

Dyspnea is a subjective experience, often described as shortness of breath, or an unpleasant awareness of breathing. It is not necessarily associated with objective measures of respiratory function such as oxygen saturation or hypoxemia. Some patients with profound dyspnea have no objective measures of impaired respiratory function and some with extensive pulmonary impairments may experience no dyspnea.¹ Dyspnea may or may not be accompanied by a cough.

Dyspnea is both common and distressing in dying patients. Ripamonti and colleagues² reported that more than 70% of hospice patients with advanced cancer or lung disease suffer dyspnea in the last 4 weeks of life. Both dyspnea and cough can negatively affect a patient's daily activities such as bathing, walking, and talking. The patient may become more isolated, dependent on others, and experience spiritual exhaustion.¹

Assessing Dyspnea

The patient's self report is the best indicator of the presence of dyspnea and the amount of distress it causes. To assess dyspnea, staff can use an adapted 0–10 intensity rating scale. (For example, “if 0 is no difficulty breathing and 10 is the most difficulty breathing you can imagine, what number describes your breathing right now?”) This same scale can be used to evaluate treatment efficacy.

Treating Dyspnea

Medical treatment should focus on identifying and treating the underlying cause of dyspnea whenever possible. Treatable conditions such as tumor obstruction, pleural effusion, ascites, infection, and anemia are associated with dyspnea in palliative care patients.³

Common interventions for managing dyspnea include both pharmacological and nondrug treatments.

Examples of nondrug interventions are

Positioning the patient (most often this is in an upright position which helps make room for the lungs to expand)

Using pillows to prop up the patient

Cool air from fans, air conditioning, or an open window

Calm, reassuring caregivers

Relaxation techniques

Pursed lip breathing

Frequently used medications and treatments include

Oxygen

Steroids

Bronchodilators

Sedatives

Oral and parenteral opioids

Anxiolytics and tranquilizers

Nebulized Medications

Opioids

Opioids have been used treat dyspnea since the end of the 19th century, although the mechanisms by which opioids are effective are poorly understood.¹ Today, opioids are a standard treatment of end-stage dyspnea. However, the systemic side effects of opioids, such as sedation, confusion, urinary retention, and constipation, sometimes are unacceptable. Nebulized opioids may relieve dyspnea by acting locally on opioid receptors in the lungs, thereby decreasing systemic side effects.

Despite the potential advantages and effectiveness of nebulized opioids, there are few published studies documenting the effectiveness of this route of administration for end-of-life dyspnea. The studies that have been published are case series in small sample sizes. There are no randomized controlled trials, which are considered the “gold standard” of establishing the efficacy of therapies. Comprehensive reviews of nebulized opioids conclude that there is no evidence to support their use in the treatment of dyspnea.4-6

The reported side effects of nebulized opioids, though rare, include respiratory depression and bronchospasm. Some authors have suggested that fentanyl may be less likely to cause bronchospasm than other nebulized opioids.5

Although there is little research to recommend this route of administration, nebulized opioids are used clinically in specific situations. Anecdotal reports support fewer dyspneic symptoms in patients who use nebulized medications. This is an important factor to consider when collaborating with physicians to provide comfort to residents who are experiencing dyspnea.

At Franciscan Hospice, we use nebulized opioids on an intermittent basis. If a patient expresses a preference for using nebulized medications, then that would be our first choice. Often we use sublingual morphine first to see how this works for the patient, as well as how easily the caregiver can administer this form. We use other opioids if a patient has had (or believes he has had) an allergic reaction from morphine. The patient's historical experience with opioids is important; we do not want to suggest something that causes increased anxiety resulting in increased dyspnea.

Other medications

Most of the literature about nebulized medications for dyspnea concerns opioids. However, other medications also are used. For example, there are case reports regarding the successful use of furosemide in terminally ill patients with dyspnea.7 Nebulized local anesthetics such as lidocaine have been used to treat cough associated with bronchoscopy, and there is anecdotal evidence for their use for persistent cough; however, they should be used with caution because they can cause anaphylactic reactions and impaired gag reflex. Moreover, they can leave a bitter taste.³

The Franciscan Hospice experience with nebulized furosemide (Lasix®) or bupivicaine is limited. In two patients, nebulized medications were ordered after traditional oral medications failed to provide relief. Furosemide was ordered for a patient who was NPO but still desired diuresis. Bupivicaine was ordered for a patient with a persistent cough who did not respond to cough syrups or oral opioids. Both patients died prior to using the medications; however, we felt comfortable offering this route as an alternative when other therapies failed.

Examples of Nebulized Medications Used in Hospice and Palliative Care

Opioids

Small Volume Nebulized (SVN) Morphine: 5–10mg with 2.5ml saline (unit dose) every 4 hours prn dyspnea, can use along with albuterol unit dose.

Hydromorphone (Dilaudid®): 2mg in 2.5ml saline every 4 hours prn shortness of breath. May use with albuterol unit dose.

Fentanyl Citrate: 25 micrograms in 2ml of saline every 2–3 hours, prn dyspnea.

Other Agents

Furosemide (Lasix®): 20–40 mg in 2.5ml saline once or twice daily, prn dyspnea caused by fluid retention.

Mucomyst®: 1–2ml of 20% solution via small volume nebulizer every 4 hours, prn thick mucous.

Bupivicaine (Marcaine®): 0.25%, 1–2 mls every 4–6 hours, prn cough; begin with 1 ml every 6 hours, titrate to relief of cough, no eating or drinking for 30 minutes to 1 hour after the treatment.

Tips for Working with Patients receiving Nebulized Medications

When using nebulized medications, remember the following:

Teach the resident not to hyperventilate and to breathe deeply during the nebulizer treatments.

Have the resident sit up during the treatments to ensure full expansion of the chest.

If holding the nebulizer is fatiguing for the resident, enlist the help of family members to assist.

Avoid the use of facemasks for nebulized treatments, as these tend to give the resident a feeling of suffocation and cause trapping of aerosolized droplets in and on the nose.

Observe the patient's technique for using the nebulizer. Instruct the patient to place the mouthpiece between his or her teeth, with the lips closed around it. Also instruct the patient to keep his or her tongue below the mouthpiece.8

Summary

Further research with larger samples of patients is needed to explore the effects of these nebulized medications. However, clinicians can assess the appropriateness of providing nebulized medications for symptom relief in their individual patients. This decision is based on the patient's and family's goals, and the efficacy or lack thereof from other forms of treatment. Providing comfort to our patients and families is the goal each of us strives for in hospice and palliative care.

--------------------------------------------------------------------------------

This month's Tip was provided by Pam Ketzner, RN, MN, CHPN, Educator, and Michael Lindgren, RPh, Pharmacist, from Franciscan Hospice, Tacoma, WA.

References

Coyne, P.J. (2003). The use of nebulized fentanyl for the management of dyspnea. Clinical Journal of Oncology Nursing, 7, 334-335.

Ripamonti C, Fulfaro F, Bruera E. Dyspnoea in patients with advanced cancer: incidence, causes and treatments. Cancer Treat Rev. 1998;24(1):69-80.

National Cancer Institute (2004). Dyspnea and coughing in patients with advanced cancer. Available at: http://www.nci.nih.gov/cancertopics/pdq/su...fessional/page2, Accessed December 16, 2004.

Jennings, A.L., Davies, A.N., Higgins, J.P., Gibbs, J.S., & Broadley, K.E. (2002). A systematic review of the use of opioids in the management of dyspnoea. Thorax, 57, 939-44

Johnson, D. (2004). Nebulized opioids for dyspnea: fact or fiction? Retrieved November 23, 2004 from Available at: www.jasonprogram.org/nebulized_opioids.htm

Joyce, M., McSweeney, M., Carrieri-Kohlman, V., & Hawkins, J. (2004). The use of nebulized opioids in the management of dyspnea: evidence synthesis. Oncology Nursing Form 31, 551-559.

Kohara, H., Ueoka, H., Aoe, K., Maeda, T., Takeyama, H., Saito, R., Shima, Y., Uchitomi, Y. (2003). Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. Journal of Pain and Symptom Management, 26, 962-7

Krames On Demand (2004). Using a nebulizer. http://www.kramesondemand.com/HealthSheet....ContentTypeId=3 Accessed December 21, 2004.

Posted

Great article Ruff Never really thought about that before...but it sounds like a good ideal.....seems feisble i guess....now the nebulized narcs are a God send to some i know when i had my problems that they calmed me down enough i wasnt struggling to breath as hard...i am all for it ...but the lasix is a new concept to me i guess time will tell

Terri

Posted

The idea of nebulized lasix has been around for about 20 years. We tried it a few times in the early 90s in PICU and NICU. Mixed results, mostly not favorable in our units.

Nebulized Morphine has been around for a long time and is used quite frequently in endstage COPD and lung CA. Nebulized steroids did prove very effective during the trial and error times of the 80s and 90s.

Effectiveness of nebulized furosemide added to nebulized salbutamol in children with acute asthma.

BACKGROUND: Nebulized furosemide has been shown to be protective against bronchoconstricting stimuli. METHODS: To investigate whether inhaled furosemide ...

Allergol Immunopathol (Madr), March 2006 http://www.medscape.com/medline/abstract/16606546

Efficacy of nebulized furosemide in children with moderate attack of asthma.

effects from bronchodilators. OBJECTIVE: To investigate the efficacy of nebulized furosemide in children with moderate asthma exacerbations. METHOD AND ...

West Afr J Med, July 2005 http://www.medscape.com/medline/abstract/16276705

Effect of nebulized furosemide in terminally ill cancer patients with dyspnea.

We evaluated the effect of ultrasonically nebulized furosemide (20 mg) on dyspnea uncontrollable by standard therapy in patients with terminal cancer. ...

J Pain Symptom Manage, October 2003

Dose-dependent evaluation of the effects of nebulized furosemide on pulmonary function in ventilated preterm infants.

OBJECTIVE: We have previously shown that a single dose of nebulized furosemide improves tidal volume and pulmonary compliance for up to a 2-hour study ...

J Perinatol, September 1998 http://www.medscape.com/medline/abstract/9766411

Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients.

Three terminal cancer patients with severe dyspnea were treated with nebulized furosemide. The underlying causes of dyspnea varied. Twenty milligrams of ...

J Pain Symptom Manage, January 2002

Nebulized furosemide for dyspnea in terminal cancer patients.

J Pain Symptom Manage, September 2002

Effect of inhaled furosemide in acute asthma.

We assessed the acute bronchodilator effect of nebulized furosemide when added to conventional therapy of acute emergency department (ED) asthma. Using a ...

J Asthma, January 1998 http://www.medscape.com/medline/abstract/9513587

Furosemide for transient tachypnea of the newborn.

picture of transient tachypnea of the newborn. Intravenous, oral or nebulized furosemide compared to placebo or no diuretic in the first 7 days. DATA ...

Cochrane Database Syst Rev, January 2002 http://www.medscape.com/medline/abstract/11869651

Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma.

Furosemide (Fur) may have an anti-inflammatory effect on airways in patients with...asthmatics. The aim of this study was to assess whether pretreatment ...

Eur Respir J, September 1999 http://www.medscape.com/medline/abstract/10543284

Posted

I have used nebulized medications of various types for years. It is just another route. The effectiveness is so variable though.. all dependent on the ability to cross the membrane and circulation.

Personally, I like nebulized steroids (such as Decadron) etc.. for those with stridor, inflammatory upper airway problems. It appears to work effective, the same way as some opioid med.'s such s Morphine etc.. I have used Lasix in neb form , but found the time of absorption was to be prolonged as it appeared to take more time to cross the membrane.

R/r 911

Posted

Rid with me the steroids didnt work neither did the albuterol so the morphine was the next thing

i had 80 mg of sol medrol ......2 neb tx and i was still in too much distress...

Posted
Rid with me the steroids didnt work neither did the albuterol so the morphine was the next thing

i had 80 mg of sol medrol ......2 neb tx and i was still in too much distress...

They used nebulized morphine with you for what?

Posted

sounds to me like it is used more in "end-of-life" situations than out on the street.

i wonder how long it would take to absorb in a real acute pulmonary enedma, and if it would pay.

Also, I think the problem with most inhaled meds is that it is very hard to get a consistent dosage. Every person inhales differently, and would therefore make accurate dosing pretty complicated on the street.

Posted

Nebulized MS; usually end of life to knock down the dyspnea centers directly.

Nebulized Lasix; usually given on a ventilator; ARDS, TTN

If given while not on a ventilator; special nebulizers to conserve aerosolized particles for more effectiveness and reduce staff and family from unnecessary med exposure.

Posted
Nebulized MS; usually end of life to knock down the dyspnea centers directly.

I'm still curious why itku2er was on neb morphine...

Posted

Well, that is her business... PM her maybe she'll tell you. She might not want to yell it across the whole forum, y'know? Caca occurs sometimes.

Wendy

CO EMT-B

MI EMT-B

This thread is quite old. Please consider starting a new thread rather than reviving this one.

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...